Nestlé S.A. (NSRGY)
| Market Cap | 269.91B |
| Revenue | 105.16B |
| Net Income | 12.96B |
| Shares Out | 2.57B |
| EPS | 4.76 |
| PE Ratio | 21.87 |
| Forward PE | 18.32 |
| Dividend | $3.41 (3.25%) |
| Ex-Dividend Date | Apr 22, 2024 |
| Volume | 118,485 |
| Open | 105.97 |
| Previous Close | 105.86 |
| Day's Range | 104.90 - 105.97 |
| 52-Week Range | 99.04 - 125.41 |
| Beta | 0.32 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About NSRGY
Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. The company operates through Zone North America; Zone Europe; Zone Asia, Oceania, and Africa; Zone Latin America; Zone Greater China; Nespresso; and Nestlé Health Science segments. It offers baby foods under the Cerelac, Gerber, Nido, and NaturNes brands; bottled water under the Nestlé Pure Life, Perrier, Vittel, Buxton, Erikli, and S.Pellegrino brands; cereals under the Fitness, Nesquik, cheerios, and Lion Cereals brands; and chocolate and confectionery produ... [Read more]
Financial Performance
In 2023, Nestlé's revenue was 93.35 billion, a decrease of -1.51% compared to the previous year's 94.78 billion. Earnings were 11.51 billion, an increase of 19.94%.
Financial numbers in CHF Financial StatementsNews
Vietnam Candy Industry Report 2024-2033, Featuring Mars Vietnam, Nestle Vietnam, Chocolaterie Guylian, Perfetti Van Melle Vietnam and Haiha Confectionery
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Vietnam Candy Industry Research Report 2024-2033" report has been added to ResearchAndMarkets.com's offering. In 2023, Vietnam's candy sales grew by 6.9%...
Nestlé reveals new food line for those on weight-loss medication
Nestlé's CEO, Mark Schneider, tells CNBC's Silvia Amaro that the group's new line of meals intended for those on GLP-1 medication is a companion range, insisting Nestlé is “not the drug manufacturer.”
We're working toward a waste-free future: Nestlé CEO
Nestlé's CEO, Mark Schneider, gives CNBC an exclusive tour of the group's research center in Lausanne to showcase new product innovations designed to reduce packaging waste.
Nestle Digital Transformation Strategy Analysis 2024: Technology Initiatives, Investments, Acquisitions, Partnerships, Network Map, ICT Budget, and Key Contracts
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Nestle S.A. - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. The report provides comprehensive i...
Nestle sees stable sales growth from Q2, CEO tells paper
Swiss food giant Nestle is targeting stable growth in sales volumes from the second quarter throughout the remainder of the year as cost inflation eases, its CEO told Swiss weekend paper "Schweiz am W...
Nestle launches website for individuals on weight loss drugs
Nestle's health unit on Tuesday launched a web platform to provide nutritional support for individuals on weight loss programs, including those using GLP-1 medications.
Seres to sell bacterial infection drug to Nestle Health for an undisclosed sum
Seres Therapeutics said on Thursday it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of its bacterial infection drug and related intellectual prope...
Nestle CEO: saw pressure among consumers in the first quarter
Nestle CEO Mark Schneider sat down exclusively with CNBC's Silvia Amaro, telling her the company saw pressure among consumers through the first quarter.
Nutritional needs for users of GLP-1 drugs are 'shifting', Nestle CEO says
Nestle CEO Mark Schneider discusses the impact of GLP-1 drugs on the food industry and the company's products that are tailored to users of the drugs.
Nestle's CEO is 'very closely' following the ultra-processed food debate
CNBC's Silvia Amaro sits down with Nestle CEO Mark Schneider for an exclusive conversation spanning food products, coffee and cocoa prices and the rise of GLP-1 drugs.
Nutritional needs are 'shifting' amid rise of weight loss drugs, says Nestle CEO
The rise of weight loss drugs means consumers' nutritional needs are "shifting," Nestle CEO Mark Schneider told CNBC's Silvia Amaro. Nestle is looking to capitalize on the popularity of the GLP-1 drug...
Nestle announces Vital Pursuit frozen-food brand targeting GLP-1 users
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Nestle's new frozen food brand, whether Americans should eat this food, and more.
Nestlé caters to the Ozempic crowd with a line of frozen meals crafted just for GLP-1 users
GLP-1 weight-loss drugs like Ozempic and Wegovy, once prescribed only to people managing conditions like diabetes, have hit the mainstream. Not only are celebrities slimming down with the injections b...
Nestlé launches food line targeting Ozempic, other weight-loss drug users
Nestlé is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years.
Ozempic users will soon get their own heat-and-eat meals
A new line of frozen foods will cater to users of weight loss drugs like Ozempic and Wegovy. Nestlé's Vital Pursuit brand will include sandwiches and bowls.
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
Nestle's Vital Pursuit brand's initial lineup of 12 items will include frozen bowls with whole grains or protein pasta, sandwich melts and pizzas.
Nestle set to sell $5 pizza, sandwiches for Wegovy, Ozempic users
Nestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as Wegovy or Ozempic for weight ...
Nestle's Nescafe to invest $196 million in Brazil by 2026 to tap surging demand
Nestle plans to invest 1 billion reais ($196.5 million) in Brazil by 2026 to expand production capacity and out-of-home sales of its Nescafe lines, targeting younger consumers, executives told Reuters...
Dr Reddy's Laboratories' CEO says Nestle has an 'amazing portfolio'
Erez Israeli, CEO of Dr Reddy's Laboratories, discusses its joint venture with Nestle India.
Unilever, Nestle slow price rises but the struggle for consumers remains
While price rises are starting to slow for companies like Nestle and Unilever after months of heading higher, the battle to win back consumers is far from over.
Nestle Sales Growth Slows Sharply on Consumer Uncertainty
Nestle's first-quarter organic sales missed forecasts as consumer demand remained weak, particularly in North America, while supply-chain disruptions continued to hold back volumes.
Nestle India unit's profit beats estimates on higher demand
Nestle India reported a bigger-than-expected increase in its quarterly profit on Thursday, as it benefited from higher product prices and demand for its packaged food items.
These are the factors driving cocoa prices to all-time highs
CNBC's Frank Holland discusses the factors fueling cocoa's price increases and which commodity appears to be next for a surge.
Indian food regulator begins enquiry into Nestle over alleged sugar use in baby foods, ET reports
The Indian food regulator has started an enquiry into Nestle India over the alleged use of sugar in baby food products in low-income countries, including India, by its Swiss parent, the Economic Times...
